NCT05226884View on ClinicalTrials.gov

Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

August 6, 2022

Study Completion Date

August 6, 2022

Conditions
Pseudophakia
Interventions
DIAGNOSTIC_TEST

Visual Acuity

Measurement of distance and intermediate visual acuity at variety targeted correction.

DIAGNOSTIC_TEST

Defocus Curve

Measurement of a defocus curve

Trial Locations (1)

77027

Berkeley Eye Center, Houston

All Listed Sponsors
lead

Berkeley Eye Center

OTHER

NCT05226884 - Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs | Biotech Hunter | Biotech Hunter